Our research group focuses on developing new mass spectrometric capabilities for measurement of biomolecules and the clinical applications of proteomics, lipidomics, and metabolomics. We aim for identification of early stage disease biomarkers and systems biological understanding of the pathogenic mechanisms underlying human diseases.

Analytical method development is driven by biomedical needs in measurement sensitivity, specificity and throughout. Many post-translational modifications to proteins are low abundant, accurate analysis of protein PTM requires specific enrichment methods. We developed online boronic affinity enrichment method for 2DLC-MS/MS analysis of glycated proteins, which has been used in identification of biomarkers to glycemic control and diabetic complications. We also developed laser capture microdissection-based methods for spatial proteomics to investigate the pathologies assoicated with specific cell types in a tissue. In addition, we developed a streamlined method for highthroughout plasma proteomics with improved proteome coverage, reproducibility and robustness.


Lipids are structurally very diverse molecules. Different classes of lipids have different chemical properties, which makes their separation and identification from a complex biological sample very challenging. We developed methods for comprehensive lipidomic analysis, which include offline 2DLC separation coupled with high resolution mass spectrometry, novel ion chemistry OzNOxESI for determination of C=C position within unsaturated lipids, isobaric chemical labeling for more sensitive and multiplexed analysis of gangliosides, and very specific method for distinguishing isomeric oxylipins.
Reliable biomarkers are greatly needed in clinics for early diagnosis of human diseases and for assessment of human performance. Our lab is the first that reported the most comprehensive profiling of longitudinal changes in plasma proteome during childhood development. Applying proteomics and lipidomics, we have identified panels of proteins that predict the onset of type 1 diabetes, established gangliosides as a critical factor in hepatitus A virus entry into the host cells and assessed functional foods in their effect on mitigating the inflammation induced by intensive exercise. This line of research is typically done collaboratively with renowned scientists and clinicians in diabetes, hepatitis, virology and sports medicine.


We developed software tools for automated processing of isotopic labeling mass spectrometry data and of the data generated by the novel OzNOxESI ion chemistry for C=C position analysis in lipids. Developing niche software to facilitate mass spectrometric data processing and data visualization will be a continous focus area of our research.
Our research lab is in the UNCG Center for Translational Biomedical Research, located on the beautiful North Carolina Research Campus in the thriving downtown Kannapolis, a suburb of Charlotte.